Center for Food Safety Policy Director Elizabeth Kucinich on mounting concerns about food safety.
Mount Sinai Health System CEO Ken Davis weighs in on the Ebola virus.
NYU Langone Medical Center’s Dr. Natalie Azar on the Ebola outbreak in Africa.
Sarepta Therapeutics CEO Chris Garabedian on its experimental drug to treat Ebola.
Dr. Devi Nampiaparampil on the Ebola virus and the effectiveness of the ZMapp treatment.
Scripps University Professor Erica Saphire on the Ebola virus and how the experimental ZMapp treatment works.
Low-T Clinic owner Mike Sisk and Urologist Dr. David Samadi on the potential benefits and risks of testosterone treatments.
FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall, FBN’s Tracy Byrnes and FOXBusiness.com reporter Kate Rogers debate the push to promote marijuana as the new medical cure-all.
Neuroeconomist Paul Zak on how hugs can make people more trusting thanks to the release of oxytocin.
Fross & Fross Wealth Management co-founder Rob Fross, Richmond Brothers founder David Richmond and AverageJoeOptions.com founder Todd Horwitz on the outlook for stocks.
Stossel and guests look at the state of the media
Shira Ovide of The Wall Street Journal on what proposed regulations mean for the drone industry.
Eli Lilly CEO John Lechleiter discusses 2Q earnings and the impact of recent patent expirations.
FOX News Medical A-Team’s Dr. Manny Alvarez on why the FDA process for approving sunscreen is slow.
Dr. Joseph Gulfo on FDA regulation and delays on sunscreen products and obesity drugs.
Consumer Reports Deputy Content Editor Lisa Gill on the potential health risks of pain medication.
UNC Assistant Professor of Medicine Dr. Kevin Campbell and Emergency Room Nurse Practitioner Erin Tolbert on the chemical Triclosan used in Colgate toothpaste.
VMR Products CEO and co-founder Jan Verleur on the company and the government’s regulations for e-cigarettes.
Johns Hopkins professor emeritus Dr. Ben Carson discusses the risk of Ebola and making a presidential run in 2016.
FBN’s Adam Shapiro on the highlights from the day in the markets.